SCHEMBL7019946

SCHEMBL7019946

CC(C)(CCOC(=O)N1CCOCC1)CC(=O)N1CCC2OCC(=O)C21

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CTSK P43235 3/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
POLB P06746 3/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.37
ALDH1A1 P00352 1/20 0.36
RECQL P46063 2/20 0.35
USP2 O75604 1/20 0.34
CTSS P25774 4/20 0.33
CTSV O60911 3/20 0.33
CTSL P07711 3/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
GAA P10253 1/20 0.32
RAB9A P51151 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4449804 0.76 CTSK (0.44) CTSKCTSSCTSVCTSL
SCHEMBL7207843 0.75 SMN1; SMN2 (0.39) CTSKSMN1; SMN2POLBLMNATSHR
SCHEMBL4449255 0.74 CTSK (0.46) CTSKSMN1; SMN2TSHRALDH1A1RECQL
SCHEMBL4449860 0.71 CTSK (0.45) CTSKSMN1; SMN2POLBCTSSCTSV
SCHEMBL4451966 0.71 CTSK (0.49) CTSKPOLBTSHRALDH1A1CTSS
SCHEMBL4207796 0.71 CTSK (0.47) CTSKCTSSCTSVCTSL
SCHEMBL4456058 0.70 CTSK (0.38) CTSKCTSSCTSVCTSL
SCHEMBL4446620 0.69 CTSK (0.47) CTSKSMN1; SMN2ALDH1A1RECQLUSP2
SCHEMBL7018963 0.69 CTSS (0.53) CTSKSMN1; SMN2ALDH1A1CTSSCTSV
SCHEMBL7017106 0.69 CTSS (0.42) CTSKLMNATSHRALDH1A1CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362052-A1 INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057270-A1 INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed